Candriam SCA’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,767
Closed -$2.22M 842
2018
Q3
$2.22M Hold
4,767
0.03% 481
2018
Q2
$1.9M Hold
4,767
0.03% 498
2018
Q1
$1.46M Hold
4,767
0.02% 533
2017
Q4
$1.4M Hold
4,767
0.02% 521
2017
Q3
$2.61M Buy
4,767
+567
+14% +$310K 0.05% 400
2017
Q2
$2.5M Buy
4,200
+3,167
+307% +$1.89M 0.05% 419
2017
Q1
$444K Buy
+1,033
New +$444K 0.01% 652